Efficient production and analysis of clinical-grade HSV-1 based gene therapy vectors.

被引：0

作者：

Ozuer, A ^{[1
]}

Wechuck, JB ^{[1
]}

Wolfe, D ^{[1
]}

Goins, WF ^{[1
]}

Wendell, S ^{[1
]}

Glorioso, JC ^{[1
]}

Ataai, MM ^{[1
]}

机构：

[1] Univ Pittsburgh, Pittsburgh, PA 15219 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

222-BIOT

引用

页码：U235 / U235

页数：1

共 50 条

[21] Engineering Cell Lines for the Production of Highly Replication Defective HSV-1 Vectors
Grant, Kyle G.
Krisky, David M.
Ataai, Mohammed M.
Glorioso, Joseph C., III
MOLECULAR THERAPY, 2006, 13 : S427 - S427
[22] INFLAMMATORY EFFECTS OF GENE-TRANSFER INTO THE CNS WITH DEFECTIVE HSV-1 VECTORS
WOOD, MJA
BYRNES, AP
PFAFF, DW
RABKIN, SD
CHARLTON, HM
GENE THERAPY, 1994, 1 (05) : 283 - 291
[23] Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors.: Evidence of cirrhosis reversion
Garcia-Bañuelos, J
Siller-Lopez, F
Miranda, A
Aguilar, LK
Aguilar-Cordova, E
Armendariz-Borunda, J
GENE THERAPY, 2002, 9 (02) : 127 - 134
[24] Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion
J Garcia-Bañuelos
F Siller-Lopez
A Miranda
L K Aguilar
E Aguilar-Cordova
J Armendariz-Borunda
Gene Therapy, 2002, 9 : 127 - 134
[25] HSV-1 thymidine kinase gene therapy for peritoneal carcinomatosis
Lechanteur, C
Princen, F
Lo Bue, S
Detroz, B
Fillet, G
Gielen, J
Bours, V
Merville, MP
GENE THERAPY OF CANCER, 1998, 451 : 115 - 119
[26] Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy
Bowers, WJ
Olschowka, JA
Federoff, HJ
GENE THERAPY, 2003, 10 (11) : 941 - 945
[27] Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy
W J Bowers
J A Olschowka
H J Federoff
Gene Therapy, 2003, 10 : 941 - 945
[28] Hsv/aav hybrid amplicon vectors:: Is AAV rep expression compatible with efficient HSV-1 DNA replication?
Fraefel, C
Baechi, T
Bittermann, AG
Meyer, C
Heister, T
Ackermann, M
CANCER GENE THERAPY, 2004, 11 (12) : 845 - 845
[29] DEVELOPMENT OF AN EFFICIENT AND SAFE ONCOLYTIC HSV-1 VECTOR FOR GLIOBLASTOMA THERAPY
Nakashima, Hiroshi
Nguyen, Tran T.
Shalkh, Imran
Goins, William F.
Chiocca, E. A.
NEURO-ONCOLOGY, 2012, 14 : 36 - 37
[30] MAKING CLINICAL GRADE GENE-THERAPY VECTORS
ANDERSON, WF
HUMAN GENE THERAPY, 1994, 5 (08) : 925 - 926

← 1 2 3 4 5 →